Skip to main content
Premium Trial:

Request an Annual Quote

Illinois Selects Tepnel CF Test for Newborn Screening

NEW YORK (GenomeWeb News) – Manchester, UK-based Tepnel Life Sciences today said that the Illinois Department of Public Health has selected its Elucigene CF-US test for two-stage testing of cystic fibrosis under a newly mandated screening program for all newborns in the state.
Tepnel’s test is designed for use on high-throughput capillary sequencers and detects 44 mutations in the cystic fibrosis transmembrane conductance regulator gene and their wild-type counterparts.
The Illinois DPH began validating the test early in 2008, Tepnel said. The first stage of the program calls for newborns to be tested for elevated levels of immunoreactive trypsin using a blood sample from the infant’s heel. If the infant’s IRT level is in the top 4 percent of the daily assay run, then their sample is tested for CF mutations using Tepnel’s test.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.